FindTrial
Sign In

Impact of pharmaceutical care on patients with type 1 diabetes mellitus seen through the judical actions.

Clinical and economic impact of pharmaceutical care in patients with type 1 diabetes mellitus seen through the judicial actions: a randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5g9wfg
Enrollment
Unknown
Registered
2019-07-19
Start date
2019-04-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin-dependent diabetes mellitus

Interventions

Experimental group: 45 patients with insulin-dependent diabetes mellitus will undergo laboratory tests and receive pharmacotherapeutic follow-up through pharmaceutical consultations. Control group: 45
Behavioural
L01.313.500.750.300.680.083

Sponsors

Universidade Federal de São João Del Rei
Lead Sponsor
Universidade Federal de São João Del Rei
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patientes with type 1 diabetes mellitus, who obtain their insulines through judical actions.

Exclusion criteria

Exclusion criteria: Bedridden patients who can not attend the place of pharmaceutical consultations.

Design outcomes

Primary

MeasureTime frame
A reduction in the levels of glycated hemoglobin, fasting glycemia, triglycerides, total cholesterol, and fractions is expected to be achieved verified through laboratory tests over a period of one year. ;We expect to see a reduction in drug costs, medical consultations and hospitalizations, verified through a reduction of these parameters, within a year.—

Secondary

MeasureTime frame
It is expected to observe a reduction in the number of drugs judicialized for the treatment of type 1 diabetes mellitus in a period of one year, which will be verified by comparing the number of medicines judicialized before and after the intervention.—

Countries

Brazil

Contacts

Public ContactThays;Thays Mendonça;Mendonça

Universidade Federal de São João Del Rei;Universidade Federal de São João Del Rei

thayssm.farmacia@gmail.com;thayssm.farmacia@gmail.com+55(37)991533976;37991533976

Outcome results

None listed

Source: REBEC (via WHO ICTRP)